Delivery Order SPE2DR25D2206-SPE2DR26F9FB9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Taltz 80 mg/ml auto-injector medication, with a ceiling value of $1,660.30. This firm fixed-price delivery order, which is scheduled for completion by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The award was made without a set-aside designation, indicating competitive award...
- The Defense Logistics Agency awarded a $11,017.75 delivery order to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,749.70 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion scheduled for December 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $18,969.16 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication on December 9, 2025, with completion scheduled for December 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $30,520.46 to supply Taltz 80 mg/ml autoinjectors. The award was made on November 28, 2025, with an ultimate completion date of December 1, 2025, under a firm fixed-price contract type with no set-aside designation. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Taltz 80 mg/ml autoinjector medication with a ceiling value of $17,030.96. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $15,731.15 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $20,092.15 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 23, 2025. The delivery is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a...
- The Defense Logistics Agency awarded a $10,932.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of TALTZ 80 mg/ml autoinjectors. This is a firm fixed price, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 7, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FB9Delivery Order
The Defense Logistics Agency awarded a $47,224 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Taltz 80 mg/ml autoinjector medication. This firm fixed-price, competitively awarded contract (with no set-aside designation) is scheduled for completion by December 10, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated capability to meet federal procurement requirements through open competition, fulfilling numerous delivery orders for specialty medications, brand-name and generic drugs, vaccines, and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the company's ongoing role as a primary pharmaceutical vendor for Department of Defense medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.2k | 12/8/25 |